Chloroquine Sensitizes Nasopharyngeal Carcinoma Cells but Not Nasoepithelial Cells to Irradiation by Blocking Autophagy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1371/journal.pone.0166766
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2016
- Urheber
- DOI
-
10.18154/RWTH-2017-00719
- URN
-
urn:nbn:de:101:1-2018062807013788028881
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Makowska, Anna
- Eble, Michael J.
- Prescher, Kirsten
- Hoß, Mareike
- Kontny, Udo
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2016
Ähnliche Objekte (12)
Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy
Suppression of autophagy by chloroquine sensitizes 5-fluorouracil-mediated cell death in gallbladder carcinoma cells
Loss of NFBD1/MDC1 disrupts homologous recombination repair and sensitizes nasopharyngeal carcinoma cells to PARP inhibitors
Glutathione depletion sensitizes rhabdomyosarcoma cells for Auranofin-induced cell death
FK228 sensitizes radioresistant small cell lung cancer cells to radiation
Albendazole sensitizes cancer cells to ionizing radiation
Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin
Hsp90 inhibition sensitizes DLBCL cells to cisplatin
Retraction Note: Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway
RETRACTED ARTICLE: Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity
HMGN1 loss sensitizes lung cancer cells to chemotherapy
Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy
Suppression of autophagy by chloroquine sensitizes 5-fluorouracil-mediated cell death in gallbladder carcinoma cells
Loss of NFBD1/MDC1 disrupts homologous recombination repair and sensitizes nasopharyngeal carcinoma cells to PARP inhibitors
Glutathione depletion sensitizes rhabdomyosarcoma cells for Auranofin-induced cell death
FK228 sensitizes radioresistant small cell lung cancer cells to radiation
Albendazole sensitizes cancer cells to ionizing radiation
Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin
Hsp90 inhibition sensitizes DLBCL cells to cisplatin
Retraction Note: Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway
RETRACTED ARTICLE: Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity
HMGN1 loss sensitizes lung cancer cells to chemotherapy
Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy
Suppression of autophagy by chloroquine sensitizes 5-fluorouracil-mediated cell death in gallbladder carcinoma cells
Loss of NFBD1/MDC1 disrupts homologous recombination repair and sensitizes nasopharyngeal carcinoma cells to PARP inhibitors
Glutathione depletion sensitizes rhabdomyosarcoma cells for Auranofin-induced cell death
FK228 sensitizes radioresistant small cell lung cancer cells to radiation
Albendazole sensitizes cancer cells to ionizing radiation
Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin
Hsp90 inhibition sensitizes DLBCL cells to cisplatin
Retraction Note: Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway
RETRACTED ARTICLE: Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity